These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11734522)

  • 21. Keratoplasty postoperative treatment update.
    Shimmura-Tomita M; Shimmura S; Satake Y; Shimazaki-Den S; Omoto M; Tsubota K; Shimazaki J
    Cornea; 2013 Nov; 32 Suppl 1():S60-4. PubMed ID: 24104936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial.
    Sinha R; Jhanji V; Verma K; Sharma N; Biswas NR; Vajpayee RB
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1167-72. PubMed ID: 20414783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic cyclosporine in high-risk keratoplasty: long-term results.
    Hill JC
    Eye (Lond); 1995; 9 ( Pt 4)():422-8. PubMed ID: 7498559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
    J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic cyclosporin A in high failure risk, repeated corneal transplantation.
    Rumelt S; Bersudsky V; Blum-Hareuveni T; Rehany U
    Br J Ophthalmol; 2002 Sep; 86(9):988-92. PubMed ID: 12185123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study.
    Birnbaum F; Mayweg S; Reis A; Böhringer D; Seitz B; Engelmann K; Messmer EM; Reinhard T
    Eye (Lond); 2009 Nov; 23(11):2063-70. PubMed ID: 19151659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats.
    Vallelado AI; López MI; Calonge M; Sánchez A; Alonso MJ
    Curr Eye Res; 2002 Jan; 24(1):39-45. PubMed ID: 12187493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systematic review of penetrating keratoplasty rejection treated by immunosuppressants].
    Sun YJ; Li AP; Pan ZQ; Luo F; Zou LH
    Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1122-7. PubMed ID: 21211228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study].
    Reinhard T; Reis A; Kutkuhn B; Voiculescu A; Sundmacher R
    Klin Monbl Augenheilkd; 1999 Sep; 215(3):201-2. PubMed ID: 10528287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty.
    Inoue K; Kimura C; Amano S; Sato T; Fujita N; Kagaya F; Kaji Y; Tsuru T; Araie M
    Jpn J Ophthalmol; 2001; 45(4):378-82. PubMed ID: 11485770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.
    Chow SP; Cook SD; Tole DM
    Cornea; 2015 Nov; 34(11):1395-9. PubMed ID: 26382894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-diameter penetrating keratoplasty: indications and outcomes.
    Skeens HM; Holland EJ
    Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Basiliximab following penetrating risk-keratoplasty--a prospective randomized pilot study].
    Birnbaum F; Jehle T; Schwartzkopff J; Sokolovska Y; Böhringer D; Reis A; Reinhard T
    Klin Monbl Augenheilkd; 2008 Jan; 225(1):62-5. PubMed ID: 18236372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Immunosuppressants in High Rejection Risk Keratoplasty: A Meta-Analysis of Comparative Studies.
    Yu K; Lian XF; Jiang XY; Zhou SY
    Cornea; 2021 Jun; 40(6):800-807. PubMed ID: 33941717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term outcome of topical cyclosporine treatment following penetrating keratoplasty].
    Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
    Nippon Ganka Gakkai Zasshi; 1999 Apr; 103(4):306-10. PubMed ID: 10339976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
    Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
    Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty.
    Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
    Jpn J Ophthalmol; 2000; 44(3):302-5. PubMed ID: 10913651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.